124 related articles for article (PubMed ID: 2173602)
1. Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.
Mak IT; Freedman AM; Dickens BF; Weglicki WB
Biochem Pharmacol; 1990 Nov; 40(9):2169-75. PubMed ID: 2173602
[TBL] [Abstract][Full Text] [Related]
2. Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical.
Suzuki S; Sato H; Shimada H; Takashima N; Arakawa M
Pharmacology; 1993 Jul; 47(1):61-5. PubMed ID: 8393194
[TBL] [Abstract][Full Text] [Related]
3. Sulfhydryl group in angiotensin converting enzyme inhibitors and superoxide radical formation.
Mehta JL; Nicolini FA; Lawson DL
J Cardiovasc Pharmacol; 1990 Nov; 16(5):847-9. PubMed ID: 1703610
[TBL] [Abstract][Full Text] [Related]
4. Self-limiting enhancement by nitric oxide of oxygen free radical-induced endothelial cell injury: evidence against the dual action of NO as hydroxyl radical donor/scavenger.
Az-ma T; Fujii K; Yuge O
Br J Pharmacol; 1996 Oct; 119(3):455-62. PubMed ID: 8894164
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.
Chopra M; Beswick H; Clapperton M; Dargie HJ; Smith WE; McMurray J
J Cardiovasc Pharmacol; 1992 Mar; 19(3):330-40. PubMed ID: 1378110
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
Liu X; Engelman RM; Rousou JA; Cordis GA; Das DK
Cardiovasc Drugs Ther; 1992 Aug; 6(4):437-43. PubMed ID: 1387799
[TBL] [Abstract][Full Text] [Related]
7. Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.
Pi XJ; Chen X
J Mol Cell Cardiol; 1989 Dec; 21(12):1261-71. PubMed ID: 2698963
[TBL] [Abstract][Full Text] [Related]
8. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors.
Chopra M; McMurray J; Stewart J; Dargie HJ; Smith WE
Biochem Soc Trans; 1990 Dec; 18(6):1184-5. PubMed ID: 2088853
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of angiotensin converting enzyme inhibitors with and without the SH-radical.
Nakagawa M; Kobayashi K; Sawada S; Toyoda T; Shirai K; Katoh K; Yamamoto K; Tsuji H; Sasaki S; Takeda K
Am J Hypertens; 1991 Jan; 4(1 Pt 2):54S-55S. PubMed ID: 1848988
[TBL] [Abstract][Full Text] [Related]
10. Effect of .OH scavenging action by non-SH-containing angiotensin converting enzyme inhibitor imidaprilat using microdialysis.
Obata T; Yamanaka Y
J Physiol Paris; 1998 Feb; 92(1):1-4. PubMed ID: 9638590
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibitors as oxygen free radical scavengers.
Mira ML; Silva MM; Queiroz MJ; Manso CF
Free Radic Res Commun; 1993; 19(3):173-81. PubMed ID: 8244086
[TBL] [Abstract][Full Text] [Related]
12. Free radical scavenging properties of alacepril metabolites and lisinopril.
Noda Y; Mori A; Packer L
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
[TBL] [Abstract][Full Text] [Related]
13. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Buikema H; Monnink SH; Tio RA; Crijns HJ; de Zeeuw D; van Gilst WH
Br J Pharmacol; 2000 Aug; 130(8):1999-2007. PubMed ID: 10952693
[TBL] [Abstract][Full Text] [Related]
14. KATP channel opening does not contribute significantly to the vasodilatory effect of SH-group-containing ACE inhibitors.
Köppel H; Holzmann S; Klein W; Horn E; Horn S; Gasser R
Heart Vessels; 1996; 11(4):192-6. PubMed ID: 9119808
[TBL] [Abstract][Full Text] [Related]
15. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
Westlin W; Mullane K
Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
[TBL] [Abstract][Full Text] [Related]
16. Prostacyclin-mediated protection by angiotensin-converting enzyme inhibitors against injury of aortic endothelium by free radicals.
Liao DF; Chen X
Cardioscience; 1992 Jun; 3(2):79-84. PubMed ID: 1379480
[TBL] [Abstract][Full Text] [Related]
17. Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta.
Mittra S; Singh M
Mol Cell Biochem; 1998 Jun; 183(1-2):63-7. PubMed ID: 9655179
[TBL] [Abstract][Full Text] [Related]
18. The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress.
Scribner AW; Loscalzo J; Napoli C
Eur J Pharmacol; 2003 Dec; 482(1-3):95-9. PubMed ID: 14660009
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.
Yue TL; Mckenna PJ; Gu JL; Cheng HY; Ruffolo RR; Feuerstein GZ
Hypertension; 1993 Dec; 22(6):922-8. PubMed ID: 7902335
[TBL] [Abstract][Full Text] [Related]
20. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues.
Zweier JL; Kuppusamy P; Lutty GA
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4046-50. PubMed ID: 2836868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
